ORYZA PHARMACEUTICALS INC. Trademark

Trademark Overview

On Thursday, September 2, 2021, a trademark application was filed for ORYZA PHARMACEUTICALS INC. with the United States Patent and Trademark Office. The USPTO has given the ORYZA PHARMACEUTICALS INC. trademark a serial number of 97009108. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Tuesday, July 22, 2025. This trademark is owned by Oryza Pharmaceuticals, Inc.. The ORYZA PHARMACEUTICALS INC. trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; Development of pharmaceutical preparations and medicines
oryza pharmaceuticals inc.

General Information

Serial Number97009108
Word MarkORYZA PHARMACEUTICALS INC.
Filing DateThursday, September 2, 2021
Status680 - APPROVED FOR PUBLICATION
Status DateTuesday, July 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

NOT AVAILABLE"PHARMACEUTICALS INC."
Goods and ServicesPharmaceutical research and development; Development of pharmaceutical preparations and medicines

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 30, 2022
Primary Code042
First Use Anywhere DateTuesday, March 15, 2016
First Use In Commerce DateTuesday, March 15, 2016

Trademark Owner History

Party NameOryza Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCoral Springs, FL 33065

Trademark Events

Event DateEvent Description
Friday, June 3, 2022NON-FINAL ACTION WRITTEN
Monday, September 6, 2021NEW APPLICATION ENTERED
Friday, October 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 31, 2022ASSIGNED TO EXAMINER
Friday, June 3, 2022NON-FINAL ACTION E-MAILED
Friday, June 3, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 29, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 29, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 30, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, January 22, 2023NON-FINAL ACTION WRITTEN
Sunday, January 22, 2023NON-FINAL ACTION E-MAILED
Sunday, January 22, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 14, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, April 14, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, July 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 10, 2023FINAL REFUSAL WRITTEN
Thursday, August 10, 2023FINAL REFUSAL E-MAILED
Thursday, August 10, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, November 9, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, November 9, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, February 8, 2024EXPARTE APPEAL RECEIVED AT TTAB
Thursday, February 8, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, February 8, 2024EX PARTE APPEAL-INSTITUTED
Thursday, December 12, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Friday, February 7, 2025EXAMINERS STATEMENT - COMPLETED
Friday, February 7, 2025EXAMINERS STATEMENT E-MAILED
Friday, February 7, 2025NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
Friday, February 28, 2025REPLY BRIEF FILED - CHECK TTAB FILES
Tuesday, June 11, 2024ACTION CONTINUING FINAL - COMPLETED
Tuesday, June 11, 2024NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Tuesday, June 11, 2024ACTION DENYING REQ FOR RECON E-MAILED
Monday, April 14, 2025EX PARTE APPEAL-REFUSAL AFFIRMED
Monday, July 14, 2025EXPARTE APPEAL TERMINATED
Tuesday, July 22, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, July 22, 2025EXAMINERS AMENDMENT -WRITTEN
Tuesday, July 22, 2025EXAMINER'S AMENDMENT ENTERED
Tuesday, July 22, 2025EXAMINERS AMENDMENT E-MAILED
Tuesday, July 22, 2025APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

pharmaceuticals oryza pharmaceutical development medicines preparations research